TABLE 1

Characteristics of Patients with Meningococcal Disease Aged 18–24 Years by College Attendance in the United States From 2014 to 2016

CharacteristicAll 18- to 24-y-Olds, N = 163By College Student Status
College Student, N = 83Noncollege Student, N = 80P
N (%)N (%)N (%)
Sex163 (100.0)83 (100.0)80 (100.0).05
 Male79 (48.5)34 (41.0)45 (56.2)
 Female84 (51.5)49 (59.0)35 (43.8)
Age, y163 (100.0)83 (100.0)80 (100.0)<.01
 1839 (23.9)21 (25.3)18 (22.5)
 1934 (20.9)29 (34.9)5 (6.3)
 2029 (17.8)17 (20.5)12 (15.0)
 2123 (14.1)12 (14.5)11 (13.8)
 229 (5.5)1 (1.2)8 (10.0)
 2316 (9.8)0 (0.0)16 (20.0)
 2413 (8.0)3 (3.6)10 (12.5)
Race135 (82.8)70 (84.3)65 (81.3).24
 White103 (76.3)57 (81.4)46 (70.8)
 African American25 (18.5)9 (12.9)16 (24.6)
 Other7 (5.2)4 (5.7)3 (4.6)
Ethnicity134 (82.2)66 (79.5)68 (85.0).06
 Hispanic25 (18.7)8 (12.1)17 (25.0)
 Non-Hispanic109 (81.3)58 (87.9)51 (75.0)
Serogroup151 (92.6)78 (94.0)73 (91.3)<.01
 B88 (58.3)60 (76.9)28 (38.4)
 C19 (12.6)3 (3.9)16 (21.9)
 W5 (3.3)1 (1.3)4 (5.5)
 Y15 (9.9)6 (7.7)9 (12.3)
 NG and/or othera24 (15.9)8 (10.3)16 (21.9)
MenACWY dose109 (66.9)61 (73.5)48 (60.0)<.01
 ≥172 (66.1)53 (86.9)19 (39.6)
 037 (33.9)8 (13.1)29 (60.4)
MenB vaccine33 (20.2)19 (22.9)14 (17.5)>.99
 ≥1 dose1 (3.0)1 (5.3)0 (0.0)
 0 doses32 (97.0)18 (94.7)14 (100.0)
Outcome153 (93.9)77 (92.8)76 (95.0).83
 Survived134 (87.6)67 (87.0)67 (88.2)
 Died19 (12.4)10 (13.0)9 (11.8)
  • NG, nongroupable; —, not applicable.

  • a Includes 22 with nongroupable and 2 with other (not specified) serogroups.